Sarcopenia in Hepatocellular Carcinoma: Pathogenesis and Management

Area of Science:

• Hepatology
• Geriatrics
• Muscle Physiology

Background:

• Sarcopenia is a frequent complication in patients diagnosed with cirrhosis and hepatocellular carcinoma (HCC).
• Chronic liver disease creates a distinct environment influencing sarcopenia development.

Purpose of the Study:

• To highlight the complex interplay of factors contributing to sarcopenia in chronic liver disease.
• To emphasize the need for comprehensive management strategies for sarcopenia in cirrhosis and HCC patients.

Main Methods:

• Review of existing literature on sarcopenia in liver disease.
• Analysis of pathophysiological mechanisms involved in sarcopenia development.
• Identification of current gaps in clinical practice and intervention studies.

Main Results:

• Sarcopenia is nearly universal in patients with cirrhosis and HCC.
• No evidence-based intervention studies are currently available for clinical practice.
• Multifactorial approach is necessary for appropriate disease management.

Conclusions:

• Effective management of sarcopenia in chronic liver disease necessitates consideration of all pathogenetic factors.
• Nutritional support, branched-chain amino acid supplementation, and physical exercise are essential components of care.
• Optimizing liver disease treatment is crucial alongside targeted interventions.